Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)

被引：0
|
作者：
Hiroki Nakajima
Sadanori Okada
Takako Mohri
Eiichiro Kanda
Naoyuki Inaba
Yoko Hirasawa
Hiroaki Seino
Hisamoto Kuroda
Toru Hiyoshi
Tetsuji Niiya
Hitoshi Ishii
机构：
[1] Nara Medical University,Department of Diabetology
[2] Tokyo Kyosai Hospital,Department of Nephrology
[3] Tokyo Medical and Dental University,Life Science and Bioethics Research Center
[4] Shizuoka Saiseikai General Hospital,Department of Metabolism & Endocrinology
[5] Plumeria DM Clinic,Department of Internal Medicine
[6] Seino Internal Medicine Clinic,undefined
[7] Green Clinic,undefined
[8] Japanese Red Cross Medical Center,undefined
[9] Matsuyama Shimin Hospital,undefined
来源：
Diabetology & Metabolic Syndrome | / 10卷
关键词：
Type 2 diabetes mellitus; Oral hypoglycemic agent; Sodium glucose cotransporters 2 inhibitors; SGLT2 inhibitors; Dapagliflozin; Treatment satisfaction; Oral Hypoglycemic Agent-Questionnaire; Body weight; Patient reported outcome; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes
    Boye, Kristina S.
    Stewart, Katie D.
    Matza, Louis S.
    DIABETES THERAPY, 2023, 14 (09) : 1451 - 1470
  • [22] Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes
    Kristina S. Boye
    Katie D. Stewart
    Louis S. Matza
    Diabetes Therapy, 2023, 14 (9) : 1451 - 1470
  • [23] Dapagliflozin Improves Endothelial Function and Microvascular Reactivity in Type 2 Diabetes Mellitus
    Korzh, Oleksii
    Titkova, Anna
    Krasnokutskiy, Sergiy
    AMERICAN HEART JOURNAL, 2020, 229 : 168 - 168
  • [24] Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes
    Katie D. Stewart
    Louis S. Matza
    Hiren Patel
    Kristina S. Boye
    Journal of Patient-Reported Outcomes, 7
  • [25] Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes
    Stewart, Katie D.
    Matza, Louis S.
    Patel, Hiren
    Boye, Kristina S.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
  • [26] Dapagliflozin Treatment for Type 2 Diabetes Mellitus Patients With Comorbid Cardiovascular Disease and Hypertension
    Cefalu, William T.
    Leiter, Lawrence A.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    DIABETES, 2012, 61 : A271 - A271
  • [27] Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study
    Alguwaihes, Abdullah M.
    DIABETES THERAPY, 2021, 12 (07) : 1979 - 1992
  • [28] An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)
    Yoshihara, Fumiki
    Imazu, Miki
    Hamasaki, Toshimitsu
    Anzai, Toshihisa
    Yasuda, Satoshi
    Ito, Shin
    Yamamoto, Haruko
    Hashimura, Kazuhiko
    Yasumura, Yoshio
    Mori, Kiyoshi
    Watanabe, Masataka
    Asakura, Masanori
    Kitakaze, Masafumi
    CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (02) : 183 - 190
  • [29] An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)
    Fumiki Yoshihara
    Miki Imazu
    Toshimitsu Hamasaki
    Toshihisa Anzai
    Satoshi Yasuda
    Shin Ito
    Haruko Yamamoto
    Kazuhiko Hashimura
    Yoshio Yasumura
    Kiyoshi Mori
    Masataka Watanabe
    Masanori Asakura
    Masafumi Kitakaze
    Cardiovascular Drugs and Therapy, 2018, 32 : 183 - 190
  • [30] Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study
    Abdullah M. Alguwaihes
    Diabetes Therapy, 2021, 12 : 1979 - 1992
12345